As part of Cytel's new Trial Innovations Webinar Series, Pat Mitchell, Statistical Science Director at AstraZeneca presented the October webinar "Formal Go/No-Go decisions are a key component of risk management in early clinical development."
Formal Go/No-Go decisions are a key component of early clinical development risk management. Pat revealed the advantages and challenges when pre-defining prospective decision criteria in the trial design to better inform verdicts on a program's fate. Pat went on to survey the current approaches utilizing dual targets in both frequentist and Bayesian frameworks.
Missed the Webinar, but interested in learning more?
Click below and enter your details to watch the replay of the presentation and access the slide deck.
2018 Trial Innovations Webinar Series
The series of webinars will resume in 2018. Be sure to follow Cytel on LinkedIn for updates.
Further reading
Case Study:
Improving Go/No Decision Making Custom Software
Blogs
Bayesian Approaches in Clinical Trials Updates on Tools Techniques
Bayesian Approaches in Benefit Risk Assesment
